ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Educational Symposium

Strategies to Manage Hyperkalemia Risk due to RAAS Blockade

November 08, 2019 | 12:45 PM - 01:45 PM

Location: Marquis Ballroom, Salon 5, Marriott Marquis

Session Description

RAAS blockade decreases the progression of kidney diseases and decreases mortality in heart failure. The development of hyperkalemia with RAAS blockade is common and creates a barrier to its optimal use. A recent study found that the development of incident hyperkalemia in CKD leads to discontinuation or dose reduction of RAAS blockade in almost one-half of patients. This step is likely taken to avoid recurrent hyperkalemia, but the non-use of RAAS blockade is associated with a greater risk of ESKD. New strategies are needed to manage the risk of hyperkalemia associated with RAAS blockade.

This symposium reviews the epidemiology of hyperkalemia, including its frequency and risk factors. Discussions include approaches to preventing recurrent hyperkalemia to allow continuation and up-titration of RAAS blockade.

Support is provided by an educational grant from Relypsa, Inc., A Vifor Pharma Group Company.

Learning Objective(s)

  • Discuss the epidemiology of hyperkalemia and recognize who is at risk
  • Develop a treatment plan for chronic hyperkalemia for patients receiving RAAS blockade

Learning Pathway(s)

  • Chronic Kidney Disease

Moderator

  • Stephen L. Seliger, MD, MS

Presentations

  • Introduction
    12:45 PM - 12:55 PM
    Stephen L. Seliger, MD, MS 
  • How Common Is Hyperkalemia and Who Is at Risk?
    12:55 PM - 01:15 PM
    David A. Bushinsky, MD 
  • What Can We Do to Prevent Recurrent Hyperkalemia for Patients Taking RAAS Blockade?
    01:15 PM - 01:35 PM
    George L. Bakris, MA, MD, FASN 
  • Questions and Answers
    01:35 PM - 01:45 PM